BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 209204)

  • 1. Quantitation of secretory component levels in cyst fluids, ascitic fluids, and sera from ovarian adenocarcinoma patients.
    Klein JL; Gall SA; Dawson JR
    J Natl Cancer Inst; 1978 Jul; 61(1):57-60. PubMed ID: 209204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of secretory immunoglobulin A (S-IgA) and secretory component (SC) in cystic fluids from ovarian tumors and ovarian cysts].
    Briese V; Brock J; Straube W
    Arch Geschwulstforsch; 1985; 55(3):197-202. PubMed ID: 3927868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoembryonic antigen isotypes in tissue sections and loose cyst fluid cells of ovarian neoplasms.
    Harłozińska A; Bar JK; Jothy S; Sedlaczek P; Slesak B; Richter R
    Tumour Biol; 1993; 14(1):1-8. PubMed ID: 7684152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The study of antibodies and antigens dissociated from the immune complexes extracted from ovarian carcinoma ascitic fluid.
    Qian HN; Feng J; Fu TY
    Gynecol Oncol; 1985 Jan; 20(1):100-8. PubMed ID: 3965372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological reactivity of mucinous and serous ovarian adenocarcinomas.
    Harłozińska-Szmyrka A; Slesak B; Richter R; Rabczyński J; Cisło M
    Cancer Detect Prev; 1986; 9(3-4):347-58. PubMed ID: 3017557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A radioimmunoassay for quantitation of secretory component.
    Kunishi K
    Gastroenterol Jpn; 1980 Apr; 15(2):144-7. PubMed ID: 7380167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possibility of immunodiagnosis in ovarian cancer.
    Chin Med J (Engl); 1978 May; 4(3):185-90. PubMed ID: 98299
    [No Abstract]   [Full Text] [Related]  

  • 8. Secretory component and immunoglobulin in human gastric carcinoma: an immunohistochemical study.
    Sumiyoshi H; Taniyama K; Ito H; Ochiai A; Yasui W; Tahara E
    Gan; 1984 Feb; 75(2):166-76. PubMed ID: 6329879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretory component and IgA in endometrial adenocarcinomas. An immunohistochemical study.
    Takeda A; Matsuyama M; Kuzuya K; Chihara T; Ariyoshi Y; Suchi T; Kato K
    Acta Pathol Jpn; 1983 Jul; 33(4):725-32. PubMed ID: 6624452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of tumor-specific antigens in human mucinous cystadenocarcinoma of the ovary by immunodiffusion.
    Chow SN; Chiang WT; Wei PY
    Int J Gynaecol Obstet; 1976; 14(3):280-4. PubMed ID: 13019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of immunoglobulins in the effusions of human ovarian epithelial neoplasms.
    Kutteh WH; Gall SA; Doellgast GJ; Allitto BA; Dawson JR
    Am J Obstet Gynecol; 1984 Sep; 150(1):65-9. PubMed ID: 6476028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of human ovarian tumor-associated antigens by antibodies isolated from ovarian carcinoma ascitic fluid.
    Rao GS; Hanjani P
    Am J Obstet Gynecol; 1988 Jul; 159(1):94-8. PubMed ID: 3394756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of human ovarian tumor-associated antigens by sandwich enzyme immunoassay.
    Rao GS; Hanjani P
    Obstet Gynecol; 1988 Mar; 71(3 Pt 1):423-8. PubMed ID: 3279355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Soluble interleukin-2 receptor level in the sera and ascitic fluids in patients with ovarian cancer].
    Pu FR; Cheng SW; Zhu D
    Zhonghua Fu Chan Ke Za Zhi; 1994 Aug; 29(8):478-80, 511. PubMed ID: 7835120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations in the levels of secretory component in human uterine fluid during the menstrual cycle.
    Sullivan DA; Richardson GS; MacLaughlin DT; Wira CR
    J Steroid Biochem; 1984 Jan; 20(1):509-13. PubMed ID: 6708533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.
    Sedlaczek P; Frydecka I; Gabryś M; Van Dalen A; Einarsson R; Harłozińska A
    Cancer; 2002 Nov; 95(9):1886-93. PubMed ID: 12404282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of IgA and secretory component in the normal and in adenocarcinomas of Fallopian tube, endometrium and endocervix.
    Lee YS; Raju GC
    Histopathology; 1988 Jul; 13(1):67-78. PubMed ID: 3209192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretory-component-producing lung cancer with hypergammaglobulinemia of secretory IgA.
    Gotoh T; Takishita Y; Doi H; Tsubura E
    Cancer; 1981 Oct; 48(8):1776-82. PubMed ID: 7284976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretory component in pulmonary adenocarcinoma and mesothelioma.
    Kondi-Paphitis A; Addis BJ
    Histopathology; 1986 Dec; 10(12):1279-87. PubMed ID: 3817763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nature of carcinoembryonic antigen purified from malignant ascitic fluid of serous cystadenocarcinoma of the ovary.
    Hill R; Daunter B; Khoo SK; Mackay EV
    Mol Immunol; 1981 Jul; 18(7):647-53. PubMed ID: 7300840
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.